Publication | Open Access
NCCN Guidelines Insights: Antiemesis, Version 2.2017
240
Citations
32
References
2017
Year
OncologyAntiemesis AddressChemotherapy-induced NauseaSymptomatic TreatmentPatient SafetyNccn Guidelines InsightsClinical GuidancePharmacotherapyMedical GuidelineMetronomic ChemotherapyCancer TreatmentMedicineRadiation OncologyAdverse Drug ReactionCancer ResearchNccn Guidelines
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis, specifically those regarding carboplatin, granisetron, and olanzapine.
| Year | Citations | |
|---|---|---|
Page 1
Page 1